VIROMED MEDICAL NA O.N. Net Asset Quality Index
VIROMED MEDICAL NA O.N. net asset quality index. VIROMED MEDICAL NA O.N. (VME) has a Net Asset Quality Index of 75.3% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €13.91 Million minus total liabilities of €3.44 Million yields net assets of €10.47 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check VME cash and liquid asset ratio to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
Net Asset Quality Index of VIROMED MEDICAL NA O.N. (2022–2025)
Net asset quality index of VIROMED MEDICAL NA O.N. from 2022 to 2025. This chart shows how VIROMED MEDICAL NA O.N.'s Net Asset Quality Index has evolved across 4 annual periods from 2022 to 2025. As of December 2025, the index stands at 75.3%, representing net assets of €10.47 Million against total assets of €13.91 Million EUR. See VIROMED MEDICAL NA O.N. (VME) shareholders funds for net asset value and shareholders' equity analysis.
VIROMED MEDICAL NA O.N. Net Asset Quality Index by Year (2022–2025)
VIROMED MEDICAL NA O.N. net asset quality index by year from 2022 to 2025. The table below presents the year-by-year Net Asset Quality Index for VIROMED MEDICAL NA O.N. from 2022 to 2025, covering 4 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see VME market cap overview.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 75.3% | €10.47 Million | €13.91 Million | €3.44 Million | ▲ +6.1 pp |
| 2024 | 69.2% | €9.27 Million | €13.40 Million | €4.13 Million | ▼ -29.0 pp |
| 2023 | 98.2% | €19.97 Million | €20.33 Million | €356.74K | ▼ -0.9 pp |
| 2022 | 99.1% | €20.08 Million | €20.26 Million | €173.57K | — |